Argenx (ARGX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Travere (TVTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
The transaction was documented in an SEC Filing. Following this sale, the insider now owns 444,418 shares of BeiGene Ltd. BeiGene Ltd (NASDAQ:BGNE) is a global biotechnology company focused on developing molecularly targeted and immuno-oncology drugs for the treatment of cancer.